2002

Dec 19, 2002
Guidant Receives CE Mark Approval for the MULTI-LINK VISION Cobalt Chromium Coronary Stent System

Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has received...

Dec 17, 2002
Guidant Completes Enrollment in Clinical Trial to Study Carotid Artery Stenting as Alternative Treatment for High Surgical-Risk Patients

Study Will Evaluate Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Dec 11, 2002
Guidant Acquires Cardiac Intelligence Corporation

Strategic Acquisition will Enhance Company Initiative to Enable Remote, Wireless Monitoring of Heart Function in Patients with Implanted Devices Indianapolis, Ind. - Guidant Corporation (NYSE and...

Dec 6, 2002
Guidant Appoints Guido J. Neels Group Chairman, Office of the President

Neels to Direct Guidant''s Worldwide Sales and Distribution Operations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 27, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Court of Appeals Denies Stay of Injunction; Cook to Move Forward with Appeal Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Nov 25, 2002
Guidant Applauds HHS Advisory Committee's Regulatory Reform Recommendations

Reforms to Promote Patient Access to Advanced Medical Technologies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Nov 22, 2002
Guidant Invests in Developer of Minimally Invasive Devices for Treatment of Lung Disease

Spiration''s Solutions Represent Potential New Treatments for Emphysema and Lung Cancer Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Nov 21, 2002
Landmark Heart Failure Therapy Study Sponsored by Guidant Achieves Primary Endpoint

COMPANION Study Stopped Due to Significant Reduction in Combined All-Cause Mortality and All-Cause Hospitalization Cardiac Resynchronization Therapy Defibrillator Arm Demonstrated Significant...

Nov 20, 2002
National Coverage Decision for Implantable Defibrillators Referred to Medicare Coverage Advisory Committee

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today reported that the Center for Medicare and Medicaid Services...

Nov 18, 2002
Guidant Introduces Innovative Next-Generation Stabilization Platform for Beating Heart Surgery

New System Designed to Simplify the Beating Heart Procedure Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Nov 15, 2002
Guidant to Highlight New Advances in Heart Failure Management During 75th Scientific Sessions of the American Heart Association

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it is providing support for a special Continuing...

Nov 15, 2002
Guidant Appoints Joseph M. Smith, M.D., Ph.D. as Chief Medical Officer for Cardiac Rhythm Management

Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Joseph M. Smith, M.D., Ph.D....

Nov 14, 2002
New National Registry Will Study Left Ventricular Dysfunction in 100,000 Patients

Scientific data-gathering effort will provide meaningful information on a cardiac condition that precedes or accompanies serious heart disease such as heart failure Indianapolis, Ind. and St....

Nov 13, 2002
Guidant and Genzyme Announce Cross-License Agreement

Deal Demonstrates Guidant's Commitment to Innovation and Intellectual Property Indianapolis, Ind. and Cambridge, Mass. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Nov 13, 2002
Guidant to Participate in the Credit Suisse First Boston Health Care Conference

Live Webcast Available Indianapolis, Ind - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Nov 8, 2002
Guidant to Host Mid-Quarter Investor Briefing

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...

Oct 30, 2002
Guidant Offers Award-Winning Women's Health Care Physician Education Program

Program Designed to Improve Prevention, Diagnosis and Treatment of Cardiovascular Disease in Women Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 25, 2002
Guidant Announces First Implants of Next Generation Heart Failure Technology

Live Broadcast of Implants Allows Physicians to Participate in Unique Training Opportunity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Oct 24, 2002
Guidant Submits Application for FDA Approval of MULTI-LINK VISION Cobalt Chromium Coronary Stent

Stent System Incorporates Innovative Material for Excellent Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 17, 2002
Guidant Reports All-Time Record Sales and Third Quarter Earnings

Quarterly Sales grew 25 percent to $827 million with Net Income of $175 million (+43 percent) and Earnings Per Share of $0.57 (+42 percent) Double-digit sales and earnings growth projected for...

Oct 11, 2002
Guidant Receives FDA Approval for its Next Generation Heart Failure Technology

Small, Physiologic-shaped CONTAK CD 2 System Combines Treatment for Both Heart Failure and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 9, 2002
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2002 earnings...

Oct 3, 2002
Guidant Receives Humanitarian Device Exemption for New Intracranial Stent

NEUROLINK Stent May Provide Hope for Patients at High Risk for Recurrent Stroke Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Oct 2, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Conference Call/Webcast Scheduled at 11AM EDT Today Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported that the United States District Court for the Northern District of...

Oct 1, 2002
Guidant Announces European Market Launch of Next-Generation Implantable Defibrillators

World''s smallest, thinnest defibrillator offers advanced rhythm discrimination and industry-leading longevity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 1, 2002
Guidant Announces FDA Clearance and Worldwide Launch of New Product for Treating Peripheral Vascular Disease

High-Performance, Low-Profile System Offers Physicians New Option Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

Sep 30, 2002
Guidant Announces Preliminary Results of Largest Drug Eluting Stent Trial To Date

Early Data from 1,533-Patient Trial Supports Safety of Paclitaxel Eluting Stents In High-Risk Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Sep 27, 2002
Guidant Announces Results of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 25, 2002
Guidant Commends New Guideline for Defibrillator Implants

New Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Sep 24, 2002
Guidant Launches Next-Generation Radiotherapy System in the United States

System Designed to Enable Physicians to Treat Long Vessel Blockages With Ease and Precision Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Sep 23, 2002
Guidant to Sponsor Symposium on the Diagnosis and Treatment of Women with Heart Disease at TCT Conference

Session to Improve Knowledge and Practices to Help Overcome Rising Mortality Rate Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Sep 23, 2002
Guidant Introduces Innovative New Device for Coronary Bypass Graft Procedures

New Technology May Reduce Risk of Major Complications Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 17, 2002
Guidant Becomes Exclusive Licensee of Everolimus for Drug Eluting Stents

Guidant Expands Agreement with Novartis Pharma AG Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today...

Sep 17, 2002
Guidant Updates Investors During Annual Investor/Analyst Conference in New York

Company Reiterates Guidance for 2002; Previews 2003 Full-Year Revenue and Earnings Per Share New York - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Sep 16, 2002
Guidant Launches Newest Coronary Stent in the United States

Sixth-Generation MULTI-LINK Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world...

Sep 10, 2002
Guidant Announces Live Webcast of its Annual Investor/Analyst Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...

Sep 9, 2002
Guidant Announces Completion of Patient Enrollment for Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Presents Significant Opportunity for Preventive Treatment Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 3, 2002
Guidant Announces European Approval to Market Paclitaxel Eluting Stent

Approval Affirms Momentum of Breakthrough Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that the...

Aug 28, 2002
Guidant Updates Investors on the Strength of the Company's Business

Company Raises Third Quarter 2002 Sales and Earnings Per Share Guidance Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Aug 28, 2002
Guidant Announces FDA Clearance and CE Mark of Next Generation Heart Failure Lead Delivery System

New System Enhances Physician''s Ability to Navigate Challenging Anatomy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 23, 2002
Guidant to Host Mid-Quarter Conference Call

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...

Aug 21, 200
American Heart Association and Guidant announce alliance to educate patients about heart failure

Online tool provides latest information about treatment options for common condition DALLAS - The American Heart Association today announced a strategic relationship with Guidant Corporation, a...

Aug 14, 2002
Guidant's MULTI-LINK Stents Demonstrate Benefit to Heart Attack Patients

CADILLAC Trial Was Largest Interventional Trial Evaluating Heart Attack Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 13, 2002
Guidant Expands Biliary Stent System Line

Additional Stent Lengths and Diameters Give Physicians Broader Treatment Options Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 8, 2002
Guidant's Stent for Small Vessels Demonstrates Excellent Clinical Outcomes at Six Months

Results Show Efficacy in Patients Presenting with Abrupt or Threatened Abrupt Closure Indianapolis, Ind. and Santa Clara, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Aug 6, 2002
Guidant Announces FDA Approval of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Ease of Handling and Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Aug 2, 2002
Guidant Partners with Prominent Venture Capital Firms to Form Vesalius Ventures

New Entity Will Identify Opportunities in Telemedicine, Clinical Informatics and Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world...

Aug 1, 2002
Guidant Invests in Innovator of Surgical Devices for Heart Surgery

Cardica, Inc. Develops Anastomotic Devices Designed to Make Procedure Faster, Easier Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jul 30, 2002
Guidant Agrees to Acquire Cook Group Incorporated

Acquisition Strategically Positions Company for Long-Term Leadership in Drug Eluting Stent Market Guidant Gains Access to Cook Group''s $500 Million Medical Technology Franchise Guidant to Hold...

Jul 22, 2002
Guidant Announces European Approval and First Implant of Next-Generation Implantable Defibrillator

Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jul 18, 2002
FDA Approves Expanded Indication for Guidant Implantable Defibrillators

MADIT II-Based Indication Provides Lifesaving Technology to Thousands of At-Risk Heart Attack Survivors Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader...

Jul 18, 2002
Guidant Reports All-Time Record Sales and Earnings

Quarterly Sales reach $807 million (+23 percent) with adjusted Net Income of $163 million (+42 percent) and Earnings Per Share of $0.53 (+41 percent) Double-digit sales and earnings growth...

Jul 2, 2002
Patient Successfully Treated for Postoperative Atrial Fibrillation Using Guidant's SYNCRUS System

New Solution Offers Fast, Effective Treatment For Common Complication After Cardiac Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jul 1, 2002
Guidant Announces Live Webcast of its Second Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2002 earnings...

Jul 1, 2002
Guidant Studies Use of Endoscopic Radial Artery Harvesting In Coronary Bypass Graft Surgery

Study Intended to Expand Indications for VASOVIEW Endoscopic Vessel Harvesting System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jun 24, 2002
Guidant to Participate in the William Blair & Co. 22nd Annual Growth Stock Conference

Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Jun 20, 2002
Guidant Supports MayoClinic.com in Heart Disease Education

Relationship Advances Efforts to Increase Patient Awareness of Disease and Therapies Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Jun 13, 2002
Guidant Reaffirms Commitment to Paclitaxel Eluting Stent Program

Guidant Comments on Summary Judgment Ruling in Cook-Boston Scientific Litigation Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported today that the United States District Court...

Jun 6, 2002
Guidant to Participate in the 23rd Annual Goldman Sachs Global Healthcare Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the 23rd Annual Goldman...

May 31, 2002
Guidant's Market-Leading MULTI-LINK PENTA Stent Demonstrates Excellent Clinical Data

Six Month Follow-Up Study Shows 17.5 Percent Binary Restenosis Rate Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

May 29, 2002
Guidant Introduces New Therapy for Treating Postoperative Atrial Fibrillation

New Option Allows Early Intervention of Common Complication Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

May 28, 2002
Guidant Announces Market Launch and First U.S. Implant of Advanced Pacemaker System

New Platform Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

May 23, 2002
Influential Figures in Guidant's History Recognized for Lifesaving Invention

Inventors of the Implantable Defibrillator Honored by the National Inventors Hall of Fame Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 23, 2002
Guidant Announces Excellent Preliminary Results of Paclitaxel Eluting Stent Trial

DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

May 22, 2002
Guidant Endovascular Solutions to Restructure

Company to Hold Mid-Quarter Call Today Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today...

May 22, 2002
Guidant Begins Clinical Trial of New Stent to Treat Bifurcated Lesions

Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the first patient has been treated in...

May 17, 2002
Guidant to Host Investor Briefing at Paris Course on Revascularization

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host an investor...

May 15, 2002
Guidant to Host Mid-Quarter Conference Call

Sixth-Generation Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

May 14, 2002
Guidant to Acquire Biosensors'' Everolimus Eluting Stent Assets

Live Webcast Available Indianapolis, Ind. - As previously announced, Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a...

May 8, 2002
Guidant Launches Next Generation Endoscopic Vessel Harvesting System

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced the launch of its fifth...

May 7, 2002
Thomas J. Linnemeier, M.D., Chief Medical Officer, Vascular Intervention, Guidant Corporation, Suffers Fatal Injuries in Automobile Accident

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation today announced that Thomas J. Linnemeier, M.D., FACC, senior vice president, new ventures and chief medical officer, Vascular...

May 6, 2002
Guidant Launches Next Generation of Market-Leading Guide Wire

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has launched the HI-TORQUE BALANCE...

May 2, 2002
Guidant Initiates New International Paclitaxel Eluting Stent Trial

Largest Study to Date, DELIVER II Will Evaluate Clinical Benefit of ACHIEVE Stent in High-Risk Patients Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

May 2, 2002
FDA Approves Guidant's System for the Treatment of Heart Failure

Only Approved Technology to Treat Both Sudden Cardiac Death and Heart Failure; Guidant to Hold Webcast Conference Call Today Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and...

Apr 30, 2002
Guidant to Participate in the Deutsche Bank Securities 27th Annual Healthcare Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the Deutsche Bank...

Apr 29, 2002
Clinsights Inc. Launches the "Drug Eluting Stent Center" on TCTMD

New York, NY, and Santa Clara, CA - Clinsights Inc. today announced the launch of the Drug Eluting Stent Center (DESC) on TCTMD - the premier online community for interventional cardiologists and...

Apr 25, 2002
Panel Finds Medtronic Infringed Guidant Rapid-Exchange Patent

Guidant Awarded $158 Million In Damages Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, reported that an arbitration...

Apr 18, 2002
Guidant Reports First Quarter Record Sales and Earnings

13 Percent Earnings Growth Leads to Earnings Per Share of $0.47, as Adjusted; Second Quarter Financial Guidance Reflects Enhanced Growth Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT),...

Apr 17, 2002
Guidant Sponsors Fellows Course to Educate Future Interventional Cardiologists

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and...

Apr 12, 2002
Guidant to Participate in the SunTrust Robinson Humphrey 31st Annual Institutional Conference

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the SunTrust Robinson...

Apr 11, 2002
Guidant Announces Live Webcast of its First Quarter Earnings Conference Call

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2002 earnings...

Apr 3, 2002
Guidant Group Chairman Ginger L. Graham Transitions to Advisor Role

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham has elected to move from her...

Apr 3, 2002
Dana G. Mead, Jr. Named Vice President, Corporate Relations and Policy

New position will have responsibility for Investor Relations, Corporate Communications, Corporate Marketing and Public Policy Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world...

Mar 27, 2002
Guidant Licenses Everolimus from Novartis for Drug Eluting Stents

Agreement with Novartis Pharma AG Broadens Guidant's Drug Eluting Stent Program Company to Host Webcast/Conference Call Today Indianapolis - Novartis Pharma AG and Guidant Corporation announced...

Mar 26, 2002
Guidant Provides Cardiac Rhythm Management New Product Update

Guidant Announces FDA Approval of INSIGNIA Advanced Pacemaker and Comments on Heart Failure Therapy Filing Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Mar 19, 2002
Guidant Announces Opening of Virtual Reality Physician Training Facility

Physicians Simulate New Interventional Procedure in a Virtual Environment Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Mar 15, 2002
Guidant Enhances Biliary Stent System Line

Additional Stent Lengths, Improved Materials and Design Give Physicians More Options and Control Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader...

Mar 14, 2002
Guidant Introduces New Product for Treating Peripheral Vascular Disease

Company Creates Dedicated Peripheral Vascular Sales Organization Indianapolis, IN and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Mar 12, 2002
Guidant to Host Investor Briefing at American College of Cardiology Meeting

Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Mar 12, 2002
Guidant Moves Advanced Patient Management Initiative Forward with CardioNet Investment

Wireless Telecommunication will Enable Internet Monitoring of Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular...

Mar 11, 2002
First European Patient Treated With Guidant's Next-Generation Beating-Heart Surgery Product

New Stabilizer Systems Designed to Make Procedure Available to More Patients Brussels, Belgium and Mainz, Germany - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Mar 7, 2002
Guidant Halts Further Development on Actinomycin-D Drug Eluting Stent Program

Company to Host Webcast/Conference Call Today Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today reported preliminary results of...

Mar 4, 2002
Guidant Completes Enrollment Of Paclitaxel Drug-Eluting Stent U.S. Trial

Clinical Trial Fully Enrolled In Less Than Four Months Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it has...

Feb 27, 2002
Guidant Announces CE Mark Approval of Next Generation Lead for Use with Heart Failure Devices

Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...

Feb 22, 2002
Guidant Comments on the Status of its ACTION Drug Eluting Stent Trial

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today issued the following statement on the status of its international ACTION...

Feb 13, 2002
Guidant Introduces Innovative Next-Generation Products for Use in Beating-Heart Surgery

New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Feb 12, 2002
Guidant and Remon to Develop Vascular Endografts with Pressure-Sensing Technology

Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...

Feb 11, 2002
Guidant Announces U.S. and European Launch of Advanced Pacing Lead

Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...

Feb 1, 2002
Guidant President and CEO is Keynote Speaker at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...

Feb 1, 2002
Guidant Announces Filing for European Approval to Market Drug Eluting Stent

ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...

Show per page

Top